To provide antibodies including modified
heavy chain constant regions, which are
heavy chain constant regions (referred to as "modified
heavy chain constant regions") or functionally equivalent fragments thereof that enhance biological properties of antibodies relative to the same antibodies in unmodified form.SOLUTION: An exemplary modified heavy chain
constant region includes an IgG2 hinge and three constant domains (i.e., CH1, CH2, and CH3 domains), wherein one or more of the
constant region domains are of a non-IgG2
isotype (e.g., IgG1, IgG3 or IgG4). The heavy chain
constant region may comprise wildtype human IgG domain sequences, or variants of these sequences. Also provided herein are methods for enhancing certain biological properties of antibodies that comprise a non-IgG2 hinge, such as
internalization, agonism and
antagonism, wherein the method comprises replacing the non-IgG2 hinge of the
antibody with an IgG2 hinge.SELECTED DRAWING: None